CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 55 filers reported holding CABALETTA BIO INC in Q3 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,379,099 | +26.2% | 222,017 | +7.1% | 0.00% | – |
| Q2 2023 | $2,677,031 | +60.0% | 207,361 | +2.5% | 0.00% | – |
| Q1 2023 | $1,673,484 | -9.6% | 202,356 | +1.1% | 0.00% | – |
| Q4 2022 | $1,851,435 | +1583.1% | 200,155 | +18.1% | 0.00% | – |
| Q3 2022 | $110,000 | -14.7% | 169,420 | +39.0% | 0.00% | – |
| Q2 2022 | $129,000 | -36.5% | 121,900 | +22.0% | 0.00% | – |
| Q1 2022 | $203,000 | +6.3% | 99,897 | +97.5% | 0.00% | – |
| Q4 2021 | $191,000 | -80.3% | 50,571 | -36.7% | 0.00% | – |
| Q3 2021 | $972,000 | +3.4% | 79,918 | -26.8% | 0.00% | – |
| Q2 2021 | $940,000 | +257.4% | 109,209 | +361.2% | 0.00% | – |
| Q1 2021 | $263,000 | -38.1% | 23,678 | -30.5% | 0.00% | – |
| Q4 2020 | $425,000 | -13.6% | 34,062 | -24.9% | 0.00% | – |
| Q3 2020 | $492,000 | +19.4% | 45,344 | +22.6% | 0.00% | – |
| Q2 2020 | $412,000 | +904.9% | 36,987 | +560.4% | 0.00% | – |
| Q1 2020 | $41,000 | -71.5% | 5,601 | -45.8% | 0.00% | – |
| Q4 2019 | $144,000 | – | 10,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,454,627 | $20,299,765 | 16.92% |
| VR Adviser, LLC | 1,973,251 | $16,318,786 | 3.19% |
| COMMODORE CAPITAL LP | 1,835,000 | $15,175,450 | 2.31% |
| Velan Capital Investment Management LP | 250,000 | $2,067,500 | 1.76% |
| Cormorant Asset Management, LP | 1,821,739 | $15,066 | 0.99% |
| CAXTON CORP | 40,581 | $335,602 | 0.85% |
| TCG Crossover Management, LLC | 486,795 | $4,025,795 | 0.78% |
| Boxer Capital, LLC | 540,000 | $4,466 | 0.22% |
| FRED ALGER MANAGEMENT, LLC | 4,015,310 | $33,206,614 | 0.18% |
| Perceptive Advisors | 724,777 | $5,993,906 | 0.18% |